Abstract
DENGUE viruses, types 1–4, are arthropod-borne flaviviruses which cause dengue shock syndrome (DSS) in humans possessing pre-infection antibody, passively acquired or derived from heterotypic infection1. Although the immuno-pathological mechanism of DSS is not fully understood, experimental studies suggest that dengue virus production is immunologically regulated. Monkeys with monotypic immunity to dengue types 1, 3 or 4 viruses, when challenged with dengue 2, had significantly higher levels of circulating virus than did similarly infected susceptible animals2. This may be attributable to the replication of virus in leukocytes. In infected monkeys, virus was frequently recovered from buffy coat cells and from lymphatic tissues3. The role of leukocytes in enhanced infection is further supported by the observation that dengue replicates readily in cultures of peripheral blood leukocytes (PBL) prepared from immune simian or human donors, but poorly or not at all in leukocytes from non-immune hosts4–6. Studies on the immunological specificity of this phenomenon have been hindered by the requirement either for expensive experimental hosts (monkeys) or for human donors with chronologically defined dengue infections. Here we describe the in vitro enhancement of dengue infection in PBL by antibody. This system provides a provisional model for DSS in young infants during primary dengue infections7,8.
Your institute does not have access to this article
Relevant articles
Open Access articles citing this article.
-
Competitive ELISA for a serologic test to detect dengue serotype-specific anti-NS1 IgGs using high-affinity UB-DNA aptamers
Scientific Reports Open Access 09 September 2021
-
Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV
BMC Veterinary Research Open Access 31 July 2021
-
The signal pathways and treatment of cytokine storm in COVID-19
Signal Transduction and Targeted Therapy Open Access 07 July 2021
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Halstead, S. B. Yale J. Biol. Med. 42, 350–362 (1970).
Halstead, S. B., Shotwell, H. & Casals, J. J. infect. Dis. 128, 15–22 (1973).
Marchette, N. J., Halstead, S. B., Falkler, W. A. Jr., Stenhouse, A. C. & Nash, D. R. J. infect. Dis. 128, 23–30 (1973).
Halstead, S. B., Chow, J. & Marchette, N. J. Nature, new Biol. 243, 24–26 (1973).
Marchette, N. J., Halstead, S. B. & Chow, J. S. J. infect. Dis. 133, 274–282 (1976).
Halstead, S. B., Marchette, N. J., Chow, J. S. S. & Lolekha, S. Proc. Soc. exp. Biol. Med. 151, 136–139 (1976).
Halstead, S. B., Scanlon, J. E., Umpaivit, P. & Udomsakdi, S. Am. J. trop. Med. Hyg. 18, 987–1021 (1969).
Halstead, S. B., Nimmannitya, S. & Cohen, S. N. Yale J. Biol. Med. 42, 311–328 (1970).
Halstead, S. B., Udomsakdi, S., Simasthien, P., Singharaj, P., Sukhavachana, P. & Nisalak, A. Yale J. Biol. Med. 42, 261–275 (1970).
Halstead, S. B., Casals, J., Shotwell, H. & Palumbo, N. Am. J. trop. Med. Hyg. 22, 365–374 (1973).
Brandt, W. E., Buescher, E. L. & Hetrick, F. M., Am. J. trop. Med. Hyg. 16, 339–347 (1967).
Sartorelli, A. C., Fischer, D. S. & Downs, W. G. J. Immun. 96, 676–682 (1966).
De Madrid, A. T. & Porterfield, J. S. Bull. Wld Hlth Org. 40, 113–121 (1969).
Böyum, A. Scand. J. clin. Lab. Invest. 21 suppl. 97, 77–89 (1968).
Halstead, S. B. Am. J. trop. Med. Hyg. 23, 974–982 (1974).
Allison, A. C. Progr. med. Virol. 18, 15–31 (1974).
Simmons, J. S., St. John, J. H. & Reynolds, F. H. K. Philipp. J. Sci. 44, 1–251 (1931).
Porter, D. D. & Larsen, A. E. Prog. med. Virol. 18, 32–47 (1974).
Hawkes, R. A. & Lafferty, K. J. Virology 33, 250–261 (1967).
Kjellén, L. E. & Schlesinger, R. W. Virology 7, 236–239 (1959).
Azuma, M. Arch. ges. Virus 41, 11–19 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HALSTEAD, S., O'ROURKE, E. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265, 739–741 (1977). https://doi.org/10.1038/265739a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/265739a0
Further reading
-
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
Journal of the Indian Institute of Science (2022)
-
COVID-19: inflammatory responses, structure-based drug design and potential therapeutics
Molecular Diversity (2022)
-
Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV
BMC Veterinary Research (2021)
-
The signal pathways and treatment of cytokine storm in COVID-19
Signal Transduction and Targeted Therapy (2021)
-
Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
npj Vaccines (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.